share_log

Denali Therapeutics(DNLI.US) Director Sells US$30,471.14 in Common Stock

moomoo News ·  Apr 17 17:54

$Denali Therapeutics (DNLI.US)$ Director SATO VICKI L sold 1,666 shares of common stock on Apr 15, 2024 at an average price of $18.29 for a total value of $30,471.14.

1713390868235114993.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment